Latest news
Shionogi (TSE:4507) Starts U.S. XOCOVA Sales As Strong Q1 Results Put Valuation In Focus - simplywall.stsimplywall.st · Fri, 07 Aug 2026 02:57:07 GMTShionogi (TSE:4507) Is Up 6.5% After U.S. Launch Of XOCOVA COVID Prophylaxis Drug – Has The Bull Case Changed? - simplywall.stsimplywall.st · Thu, 30 Jul 2026 08:36:24 GMTShionogi’s Xocova now available in USA - The Pharma LetterThe Pharma Letter · Wed, 29 Jul 2026 12:23:39 GMT